Orasure Technologies (OSUR) Income from Continuing Operations (2010 - 2025)
Orasure Technologies (OSUR) posted Income from Continuing Operations of 13338000.0 for Q3 2025, up 29.39% sequentially from 18891000.0 in Q2 2025, and down 240.43% YoY from 9498052.34 in Q3 2024.
Orasure Technologies (OSUR) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Income from Continuing Operations for 16 years, with the latest figure at 13338000.0 in Q3 2025.
- Quarterly Income from Continuing Operations fell 240.43% year-over-year to 13338000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 57966000.0 (down 562.14% YoY) and the FY2024 annual result came in at 17800000.0, down 133.17% from the prior year.
- Income from Continuing Operations improved to 13338000.0 in Q3 2025 per OSUR's latest filing, from 18891000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 27219000.0 in Q1 2023 and troughed at 19940000.0 in Q1 2022.
- A 5-year average of 2733578.95 and a median of 3918000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations soared 252.04% in 2022, then slumped 25428.38% in 2025.
- Over 5 years, Income from Continuing Operations stood at 10393000.0 in 2021, then jumped by 252.04% to 15801000.0 in 2022, then gained by 27.31% to 20117000.0 in 2023, then tumbled by 151.03% to 10265000.0 in 2024, then slipped by 29.94% to 13338000.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 13338000.0, 18891000.0, and 15472000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.34 Mn |
| Jun 30, 2025 | -18.89 Mn |
| Mar 31, 2025 | -15.47 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -3.92 Mn |
| Jun 30, 2024 | -74,000.00 |
| Mar 31, 2024 | -3.58 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 11.16 Mn |
| Jun 30, 2023 | -4.76 Mn |
| Mar 31, 2023 | 27.22 Mn |
| Dec 31, 2022 | 15.80 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | -18.59 Mn |
| Mar 31, 2022 | -19.94 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -15.02 Mn |
| Jun 30, 2021 | -1.36 Mn |
| Mar 31, 2021 | 3.77 Mn |
| Dec 31, 2020 | -43.40 Mn |